New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
12:38 EDTBIRT, CVS, SSYS, USNA, GOOG, DDD, MYGN, MRKOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday after ADP reported that dismal weather in January put a damper on private sector hiring. The market seemed indecisive in the opening 30 minutes of trading, but soon picked up downside momentum. The Nasdaq, which was down more than 1% early in the session, has trimmed its losses and the Dow has moved into positive ground, though just barely. ECONOMIC EVENTS: In the U.S., payroll company ADP reported that 175,000 service jobs were created in January, versus the expectations for 185,000 net new positions to have been added. The ISM services index rose to 54.0 in January from December's 53.0 reading, which was a bit ahead of expectations. COMPANY NEWS: Dow component Merck (MRK) advanced fractionally after the drug company’s quarterly results were generally in-line with expectations and it also announced three clinical collaboration agreements to evaluate its investigational anti-PD-1 immunotherapy… Shares of Google (GOOG) are advancing in a down market after the search giant reached a settlement with European Union regulators over antitrust allegations and research firm Bernstein hiked its price target on the stock to $1,500 from $1,350... CVS Caremark (CVS) announced plans to cease selling all tobacco products, including cigarettes, at all its locations starting October 1. MAJOR MOVERS: Among the notable gainers was multi-level-marketer USANA Health Sciences (USNA), which rose 17% after its results and guidance beat expectations. Also higher were shares of molecular diagnostic company Myriad Genetics (MYGN), which climbed over 11% after the company reported second quarter results that beat consensus expectations, raised its fiscal 2014 outlook, and announced the acquisition of Crescendo Bioscience. Among the noteworthy losers was 3D Systems (DDD), which plunged 16% after the maker of 3D printers and supplies lowered its profit outlook for the current fiscal year and guided to earnings next year below the consensus estimate. A number of 3D Systems’ peers fell as well, with the next biggest company in the sector, Stratasys (SSYS), also declining 3%. Also lower were shares of Actuate (BIRT), which slid about 17% after reporting earnings, announcing the acquisition of German software developer legodo ag and being downgraded at Drexel Hamilton. INDICES: Near midday, the Dow was up 13.12, or 0.08%, to 15,458.36; the Nasdaq was down 13.59, or 0.34%, to 4,017.93; and the S&P 500 was down 2.14, or 0.12%, to 1,753.06.
News For DDD;SSYS;MRK;GOOG;CVS;MYGN;USNA;BIRT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
February 24, 2015
16:28 EDTMYGNMyriad Genetics board approves $200M increase in share buyback program
Subscribe for More Information
13:23 EDTCVSLeerink healthcare technology analyst holds analyst/industry conference call
Healthcare Tech & Distribution Analyst Larsen discusses th 2016 Pharmacy Benefits Management (PBM) selling season, the impact of the Hep C PBM formulary negotiations on the selling season and specialty drug trend and areas of opportunity for PBMs on an Analyst/Industry conference call to be held on March 5 at 2 pm.
11:02 EDTSSYSStratasys announces promotions within MakerBot unit
Stratasys announced the transitioning of key executives and expanding responsibilities within its MakerBot business. Jenny Lawton, chief executive officer of MakerBot, will be promoted to executive VP Special Projects for Stratasys and will report directly to CEO David Reis in his capacity as the company’s chief business officer. Jonathan Jaglom, general manager from Stratasys Asia Pacific Japan, will be promoted to chief executive officer of MakerBot.
08:15 EDTDDD3D Systems volatility elevated into Q4 and outlook
Subscribe for More Information
06:49 EDTGOOGGoogle bans sexually explicit content from websites hosted on Blogger
Subscribe for More Information
06:39 EDTGOOGVisa Europe announces 'tokenisation service'
Subscribe for More Information
06:34 EDTGOOGGoogle said to be rearranging engineers in Glass department, 9to5Google reports
Subscribe for More Information
05:17 EDTMRKMerck collaborates with Medicines Patent Pool to expand Raltegravir access
Subscribe for More Information
February 23, 2015
12:33 EDTGOOGAndroid antitrust lawsuit against Google dismissed, Reuters says
Subscribe for More Information
12:28 EDTGOOGGoogle reaches deal with wireless carriers, acquires Softcard tech, Re/code says
Subscribe for More Information
09:39 EDTGOOGActive equity options trading on open
Subscribe for More Information
09:39 EDTGOOGYouTube confirms launch of kids app
Google's (GOOG, GOOGL) YouTube confirmed its launch of the YouTube Kids app, "the first Google product built from the ground up with little ones in mind," which the company said makes it safer and easier for children to find videos on topics they want to explore. The app is now available for free on Google Play and the App Store in the U.S. Reference Link
08:27 EDTMRKNGM Biopharmaceuticals to hold a teleconference
NGM Biopharm discusses the strategic collaboration with Merck to discover, develop and commercialize novel biologic therapeutics on a teleconference to be held on February 23 at 9:30 am. Webcast Link
08:24 EDTGOOGGoogle Vietnam site disrupted by hackers, WSJ says
Subscribe for More Information
07:04 EDTMRKMerck, NGM Biopharmaceuticals announce multi-year collaboration
NGM Biopharmaceuticals and Merck announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas. This agreement will become effective upon the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The collaboration includes multiple drug candidates currently in preclinical development at NGM, including NP201, which is being evaluated for the treatment of diabetes, obesity and nonalcoholic steatohepatitis. NGM will lead the research and development of the existing preclinical candidates and have the autonomy to identify and pursue other discovery stage programs at its discretion. Merck will have the option to license all resulting NGM programs following human proof of concept trials. If Merck exercises this option, Merck will lead global product development and commercialization for the resulting products, if approved. Under the terms of the agreement, Merck will make an upfront payment to NGM of $94M and will purchase a 15 percent equity stake in NGM for $106M at a price per share that represents a 20% premium to NGM’s most recent financing. Merck will commit up to $250M to fund all of NGM’s efforts under the initial five-year term of the collaboration, with the potential for additional funding if certain conditions are met. Prior to Merck initiating a Phase 3 study for a licensed program, NGM may elect to either receive milestone and royalty payments or, in certain cases, to co-fund development and participate in a global cost and revenue share arrangement of up to 50%. The agreement also provides NGM with the option to participate in the co-promotion of any co-funded program in the United States. Merck will have the option to extend the research agreement for two additional two-year terms.
06:31 EDTGOOGGoogle reaches preliminary agreement with Italian regulators, WSJ says
Subscribe for More Information
February 20, 2015
07:42 EDTGOOGFDA authorizes 23andMe to market genetic testing for Bloom Syndrome
The U.S. Food and Drug Administration yesterday authorized for marketing Google-backed 23andMe’s Bloom Syndrome carrier test, a direct-to-consumer genetic test to determine whether a healthy person has a variant in a gene that could lead to their offspring inheriting the serious disorder. Along with this authorization, the FDA is also classifying carrier screening tests as class II. In addition, the FDA intends to exempt these devices from FDA premarket review. The agency plans to issue a notice that announces the intent to exempt these tests and that provides a 30-day period for public comment.
07:08 EDTMRKAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
06:22 EDTGOOGYouTube to release stand-alone app for kids, WSJ says
Google's YouTube is planning to release a smartphone and tablet app for kids featuring original episodes of television shows including "Thomas the Tank Engine" and "Sesame Street," as well as content from existing YouTube kids channels, reports the Wall Street Journal, citing a person familiar with the matter. The app -- slated for an official reveal Monday at the Kidscreen Summit -- will initially only be available for Android devices. The source said the inclusion of ads is "under discussion." Reference Link
05:20 EDTDDD3D Systems implied volatility of 68 at upper end of index mean range
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use